U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07135037) titled 'Comparison Between Treatments of Oligohydramnios' on June 09.
Brief Summary: Based on previous studies, Both sildenafil and L-arginine helped to improve idiopathic oligohydramnios.
In this study, Level of improvment of oligohydramnios will be compared. As well as, NICU admission to neonates of pregnancies complicated by idiopathic oligohydramnios. The end goal is to help physicians use the best drug for their patients.
Study Start Date: Sept. 01, 2024
Study Type: INTERVENTIONAL
Condition:
Oligohydramnios
Intervention:
DRUG: Sildenafil 25 MG
Sildenafil is a vasodilator drug which improve blood supply to placenta.Therefore, it...